| |
| |
|
| Insider
Information: |
Lea Leiv |
| Relationship: |
Chief Financial Officer |
| City: |
Sunnyvale |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
16,000 |
|
|
Indirect Shares
|
287,337 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$542,292 |
|
|
| Total
Shares |
303,337 |
|
|
| Total
Value |
$542,292 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 67.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmacyclics Inc |
PCYC |
VP Fin & Admin & CFO |
2008-04-30 |
16,000 |
2008-04-30 |
4,893 |
Premium* |
|
|
Corvus Pharmaceuticals, Inc. |
CRVS |
Chief Financial Officer |
|
0 |
2022-12-14 |
282,444 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRVS |
Corvus Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2022-12-14 |
4 |
B |
$0.84 |
$3,364 |
I/I |
4,000 |
133,238 |
1.91 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2022-12-13 |
4 |
B |
$0.74 |
$22,275 |
I/I |
30,000 |
129,238 |
1.99 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2022-03-17 |
4 |
B |
$1.65 |
$22,899 |
I/I |
13,878 |
99,238 |
1.99 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2022-03-16 |
4 |
B |
$1.54 |
$54,146 |
I/I |
35,160 |
85,360 |
1.99 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2019-06-07 |
4 |
B |
$3.38 |
$33,800 |
I/I |
10,000 |
50,200 |
1.99 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2019-06-06 |
4 |
B |
$3.56 |
$55,180 |
I/I |
15,500 |
40,200 |
1.99 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2018-12-21 |
4 |
B |
$4.15 |
$102,409 |
I/I |
24,700 |
24,700 |
1.99 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2016-03-29 |
4 |
A |
$0.00 |
$0 |
I/I |
42,608 |
199,253 |
0 |
- |
|
| CRVS |
Corvus Pharmaceuticals, I... |
Chief Financial OfficerOfficer |
• – – |
2016-03-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
156,645 |
|
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2008-04-30 |
4 |
A |
$0.72 |
$723 |
D/D |
1,000 |
7,000 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2007-10-31 |
4 |
A |
$1.84 |
$1,836 |
D/D |
1,000 |
6,000 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2007-08-22 |
4 |
B |
$2.01 |
$6,030 |
D/D |
3,000 |
5,000 |
2.74 |
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2007-08-21 |
4 |
B |
$2.02 |
$4,040 |
D/D |
2,000 |
2,000 |
2.66 |
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2007-04-30 |
4 |
A |
$2.79 |
$2,788 |
D/D |
1,000 |
5,000 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2006-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,893 |
9,000 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2006-12-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,893 |
4,893 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2006-12-18 |
4/A |
GA |
$0.00 |
$0 |
I/I |
3,893 |
4,893 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2006-12-18 |
4/A |
GD |
$0.00 |
$0 |
D/D |
3,893 |
4,000 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2006-10-31 |
4 |
A |
$4.58 |
$4,582 |
D/D |
1,000 |
8,893 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2006-04-28 |
4 |
A |
$4.87 |
$4,870 |
D/D |
1,000 |
7,893 |
|
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2005-10-31 |
4 |
A |
$4.93 |
$4,930 |
D/D |
1,000 |
6,893 |
|
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2005-04-29 |
4 |
A |
$4.93 |
$4,930 |
D/D |
1,000 |
5,893 |
|
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2004-10-29 |
4 |
A |
$4.93 |
$4,930 |
D/D |
1,000 |
4,893 |
|
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2004-04-30 |
4 |
A |
$4.93 |
$3,338 |
D/D |
677 |
3,893 |
|
- |
|
| PCYC |
Pharmacyclics Inc |
VP Fin & Admin & CFO |
• – – |
2003-10-30 |
4 |
B |
$4.79 |
$1,294 |
D/D |
270 |
2,216 |
2.66 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
